Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Shuttle Pharmaceuticals Holdings, Inc. is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes for cancer patients treated with radiation therapy (RT). Its product candidates include Ropidoxuridine, a Phase II, clinical-stage radiation sensitizer, a platform of HDAC inhibitors (SP-1-161, SP-2-225 and SP-1-303), and two preclinical, prostate cancer-oriented diagnostics assets: PC-RAD Test, a blood test to predict clinical response to radiation therapy and PSMA-B ligand for potential use as a theranostic agent. Ropidoxuridine (IPdR) is for use in combination with RT to treat brain tumors (glioblastoma) and sarcomas. SP-1-161 is a candidate lead of compounds demonstrating activation of the ATM gene product (mutated in Ataxia-Telangiectasia). SP-2-225 is a candidate lead of compounds demonstrating Class II (HDAC6) selective inhibition. SP-1-303 is a candidate Class I HDAC inhibitor with preferential efficacy against ER positive cancers.
Find out what a historical investment in Shuttle Pharmaceuticals Holdings Inc would be worth today using our SHPH stock calculator.
Buying SHPH shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Shuttle Pharmaceuticals Holdings Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in SHPH
What is the ticker symbol of Shuttle Pharmaceuticals Holdings Inc?
The ticker symbol for Shuttle Pharmaceuticals Holdings Inc is SHPH.
How much is one share of SHPH?
One share of SHPH is valued at $3.90 as of 20 November 2026.
What is the market capitalisation of Shuttle Pharmaceuticals Holdings Inc SHPH?
As of 20 November 2026 Shuttle Pharmaceuticals Holdings Inc has a market cap of $18.22M.
What is the 52-week high for Shuttle Pharmaceuticals Holdings Inc stock?
The Shuttle Pharmaceuticals Holdings Inc 52-week high stock price is $44.40.
What is the 52-week low for Shuttle Pharmaceuticals Holdings Inc stock?
The Shuttle Pharmaceuticals Holdings Inc 52-week low stock price is $2.58.
Can I buy SHPH shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy SHPH shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SHPH on Stake
Buy SHPH from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of SHPH from only US$10 with fractional shares